Since its introduction to the pharmaceutical market in the mid-1990’s, the antidepressant medication Effexor has consistently been a top choice for mental health professionals in the […]
The antidepressant medication Effexor has been linked to several different kinds of birth defects, especially if taken early in a pregnancy. Many of these associated birth […]
The serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant medication Effexor (generic Venlafaxine) has been prescribed to over 17 million patients since it arrived on the market in the […]
Research performed by the National Birth Defects Prevention Study suggests that taking the antidepressant medication Effexor while pregnant can greatly increase the risk of having a […]
Research studies have implied that neurotransmitters are morphogens and have the capability to send signals to molecules during fetal development. One neurotransmitter in particular, serotonin, is […]
Because serotonin acts as a morphogen and sends messages regarding development during embryogenesis, an SNRI (serotonin-norepinephrine reuptake inhibitor) medication, like Effexor, can adversely affect a baby […]
Data released by the National Birth Defects Prevention Study in August of 2011 suggests that the likelihood of a baby being born with the congenital heart […]